Navigation Links
Kidney function discovery sheds light on genetic complexity of disease
Date:11/26/2008

sor Stefan Broer, School of Biochemistry and Molecular Biology at ANU.

"From the point of view of understanding complex diseases in humans, it suggests we need to integrate much greater levels of complex genetic information to reach a clear understanding."

Professor Rasko says that these findings provide a foundation to improve our understanding of common human diseases, and greater potential to develop effective gene therapies to reduce the impact of diseases on patients.

"Gene therapies, whereby cells can be modified and then re-introduced into the body without the genetic mutations that cause illness, provide enormous potential to help cure diseases including haemophilia, cancer and cardiovascular disease," Professor Rasko explains.

"A crucial ingredient of successfully developing gene therapies is a thorough understanding of all the genetic factors at play in disease. This discovery takes us one step closer to understanding the complex factors at work in these serious diseases."


'/>"/>

Contact: Erin Sharp
e.sharp@centenary.org.au
029-565-6118
Research Australia
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Diet support helps chronic kidney patients
2. Genetic breakthrough offers promise in tackling kidney tumors
3. Northwestern Memorial trial may wean kidney transplant patients off antirejection drugs
4. Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines
5. Gaining a better understanding of kidney diseases
6. High blood pressure takes big toll on small filtering units of the kidney
7. Scientists identify cell changes leading to impaired artificial kidney function
8. Geron Demonstrates hESC-derived cardiomyocytes improve heart function after myocardial infarction
9. Device helps patients survive, regain function til transplant
10. Specific brain protein required for nerve cell connections to form and function
11. Systems Biology poised to revolutionize the understanding of cell function and disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...ricket fights has been part of Chinese cultural tr...1278). This ancient practice has resulted in quite...ractitioners think make for champion fighters. "Be...tive for the practitioners of this sport to observ...e, a biology postdoctoral researcher at University...
(Date:1/7/2009)...an oral drug therapy called fenobam has shown prom... treatment option for adult patients with Fragile ...gle-dose study by researchers at Rush University M...vis, Medical Center are to be published in the upc...etics . , Results of an initial evaluation of ...
(Date:1/7/2009)...ational Human Genome Center at Shanghai (South Cen...g HiTech Park of Pudong District in Shanghai. To c... beginning of the Genomics Era in China, we specia...pecial issue. We hope that this effort may draw th...orkers ,to collectively recall the short but frui...
(Date:1/7/2009)... Currently, plant testing in the United States to...l pesticides to nontarget plants requires two test...f the plant development and reproduction are not c...n of animals. Past research conducted by the USEPA...oduction is not adequately protected with the curr...
Breaking Biology News(10 mins):Male crickets with bigger heads are better fighters, study reveals, echoing ancient Chinese text 2Promising new drug being evaluated as possible treatment option for fragile X syndrome 2Human genomics in China 2Human genomics in China 3Human genomics in China 4Human genomics in China 5Human genomics in China 6Human genomics in China 7Human genomics in China 8Human genomics in China 9Human genomics in China 10Human genomics in China 11Pharmasset Commences Dosing in 28 Day Combination Study of R7128 with Pegasys 28R 29 plus Copegus 28R 29 for Hepatitis C 430 1Pharmasset Commences Dosing in 28 Day Combination Study of R7128 with Pegasys 28R 29 plus Copegus 28R 29 for Hepatitis C 430 2Pharmasset Commences Dosing in 28 Day Combination Study of R7128 with Pegasys 28R 29 plus Copegus 28R 29 for Hepatitis C 430 3Pharmasset Commences Dosing in 28 Day Combination Study of R7128 with Pegasys 28R 29 plus Copegus 28R 29 for Hepatitis C 430 4Pharmasset Commences Dosing in 28 Day Combination Study of R7128 with Pegasys 28R 29 plus Copegus 28R 29 for Hepatitis C 430 5Health Net and Bank of America Launch Partnership 2710 1Health Net and Bank of America Launch Partnership 2710 2Health Net and Bank of America Launch Partnership 2710 3Orthofix International Acquires InSWing 28TM 29 Interspinous Process Spacer 2707 1Orthofix International Acquires InSWing 28TM 29 Interspinous Process Spacer 2707 2Orthofix International Acquires InSWing 28TM 29 Interspinous Process Spacer 2707 3Pelosi Statement on National Breast Cancer Awareness Month 2703 1
...grates connections map data into BiblioSphere , G...n for the Advancement of Science (AAAS) today anno... from the Signal Transduction Knowledge Environmen...e base and analysis system. , AAAS, publisher of ...tion Knowledge Environment, an enhanced online jou...
...sity researchers have discovered the 3-D crystal s...to important discoveries about how cells release c...process. The findings also may offer insights into...from leukemia to diabetes and HIV-AIDS. , Levels...eople fall ill, making human CD38 a marker for the...
... the National Institute of Child Health and Human ...the malaria parasite disperses from the red blood ... Health and Human Development is one of the Instit... , The study appears in the September 20 Current B... for possible new approaches to treating malaria, ...
...istance has put humans in an escalating ,arms race...evelop new antibiotics faster than the bacteria ca...archers have a new strategy that may give them a l...tural evolution of the bacterial enzymes that conf... and Mexico identified mutations that increased th...
Other Biology News:Genomatix, AAAS ink agreement 2Protein structure key for AIDS, cell function 2Researchers discover how malaria parasite disperses from red blood cells 2Researchers discover how malaria parasite disperses from red blood cells 3Gaining ground in the race against antibiotic resistance 2Gaining ground in the race against antibiotic resistance 3
(Date:1/8/2009)... Dendreon Corporation (Nasdaq: DNDN ) today anno...ual J.P. Morgan Healthcare Conference in San Franc...T. , , , A live audio webcast of the present...tions section of the Dendreon website, http://www... live webcast, it will be archived on the site fol...
(Date:1/8/2009)... -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) ...resent at the 27th Annual J.P. Morgan Healthcare C... Time (6:00 p.m. Eastern Time) at the Westin St. F...President and Chief Executive Officer, is schedule... its clinical development and discovery programs. ...
(Date:1/8/2009)...onference on Health Informatics (HEALTHINF 2009) w...ed "Open Source in European Health Care: The ...o, Portugal (PRWEB) January 8, 2009 -- OpenClinica...coming International Conference on Health Informat... Portugal. The workshop, titled "Open Source ...
(Date:1/7/2009)...e-FirstCall/ -- Nuvelo, Inc.,(Nasdaq: NUVO ) to... approved,the issuance of Nuvelo Common Stock pur... 2008, as amended, between Nuvelo, ARCA biopharma ...so voted to adjourn Nuvelo,s special,stockholder ...nal proxies in,favor of a proposal to amend the C...
Breaking Biology Technology:Arena Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference 2Arena Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference 3OpenClinica to Present at International Conference on Health Informatics, January 14-17, Porto, Portugal 2Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 2Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 3Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 4Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 5
... Recently the Wisconsin Technology Network sat do... Technology Council , to discuss the basic tenants...h to help Wisconsins technology space grow. This i... the technological challenges Wisconsin faces and ... overcome them. , , Wisconsin Technology Network:...
...The sign hanging over the Badger state pavilion at...Room to Breathe. But you had to visit the New York...at that states oxygen bar. , ,In a business that h...st states, provinces and even nations are eager to... the world of bio-branding. , ,Wisconsins Room to ...
...letter know that I,ve written regularly about so- ... Spoke, and Google,s Orkut. These columns have run...nd they have questioned the value of these network...al, really; I just didn,t see a clear and viable b...t weeks, I,ve experienced one "a-ha" moment after ...
...omy is currently undergoing a historical transform...nce World War I, when the paper, brewing, automoti...ourish. , ,The change from an agriculture and ma... innovation-based economy is inevitable. Wisconsi...ce and losing thousands of manufacturing jobs to t...
Other Biology Technology:WTN exclusive interview with Tom Still, Wisconsin Technology Council 2WTN exclusive interview with Tom Still, Wisconsin Technology Council 3WTN exclusive interview with Tom Still, Wisconsin Technology Council 4WTN exclusive interview with Tom Still, Wisconsin Technology Council 5Whats in a name? Quite a bit, when youre competing in biotech 2Social networks and my big a-ha 2Social networks and my big a-ha 3Social networks and my big a-ha 4Educate, innovate and execute: Wisconsins model for success 2Educate, innovate and execute: Wisconsins model for success 3
Naphthol Blue Black, CI 20470
Recognizes rat Taste Receptor 2 (TR2). The immunogen shows no significant sequence homology with TR1, gustducin or other pheromone receptors.
Mouse monoclonal [YPF19] to Yersinia pestis This antibody is used to detect Yersinia pestis . Immunogen: Purified F1 antigen from Yersinia pestis vaccine strain EV76. Specificity: This antib
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody
Biology Products: